Navigation Links
Isis Reports Strong Financial Results and Highlights for First Quarter of 2009
Date:5/7/2009

- Conference Call Webcast Thursday, May 7, 08:30 a.m. EDT at www.isispharm.com

CARLSBAD, Calif., May 7 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced its financial results for the quarter ended March 31, 2009. Primarily as a result of the $171.8 million gain that Isis recognized from selling its Ibis Biosciences subsidiary to Abbott Molecular Inc. (AMI), Isis finished the first quarter of 2009 with pro forma net income of $173.0 million. Isis also reported pro forma net operating income of $2.1 million for the first quarter of 2009 compared to a net operating loss (NOL) of $3.0 million in the first quarter of 2008. The improvement in Isis' operating results from the first quarter of 2008 was primarily due to an increase in revenue from its strategic alliance with Genzyme, which was completed in the second quarter of 2008. On a GAAP basis, Isis' net income of $171.8 million and loss from operations of $642,000 for the first quarter of 2009 also improved significantly from its net loss and loss from operations in the first quarter of 2008. The sale of Isis' diagnostic subsidiary, Ibis, not only was a substantial contributor to Isis' first quarter net income, but the $175 million Isis received from completing the transaction also considerably increased Isis' cash position. Isis ended the quarter with $652 million in cash, cash equivalents and short-term investments.

"We ended 2008 in the strongest financial position in our history, and our financial strength continued to improve this quarter. Already this year, we have received over $200 million in cash, including the $175 million we received at the beginning of the year from our sale of Ibis," said B. Lynne Parshall, COO and CFO of Isis. "Our strong financial position is a result of t
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... 02, 2015 , ... Ericson is a noted speaker and educator in the ... Director of Education for the Association for Clinical Documentation Improvement Specialists (ACDIS) where she ... Camps. She serves as a CDI subject matter expert for a variety of HCPro ...
(Date:9/2/2015)... ... 2015 , ... The 2015 China Overseas Investment and Entrepreneurship ... conference will be hosted at five star Beijing Kunlun Hotel and Diaoyutai State ... feature leading EB-5 industry professionals and Chinese private equity partners looking for international ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... the upper extremity surgical market, announced today that more than 600 successful patient ... in the hand. Plus, nearly 70 of these procedures have been on ...
(Date:9/2/2015)... , ... September 02, 2015 , ... On September 9, ... attend doTERRA’s annual convention, the largest single-company convention to date for the state of ... look forward to a tremendous event,” states David Stirling, doTERRA CEO. “One of the ...
(Date:9/2/2015)... ... , ... The payroll conference theme this year is "TAKING ... legislative updates, including unemployment, global payroll best practices, and the latest trends in ... the American Payroll Association, Barnett Associates, and the IRS, will keep payroll professionals ...
Breaking Medicine News(10 mins):Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:23rd Annual NJ Statewide Payroll Conference in Vernon, NJ at the Minerals Hotel on October 15-16, 2015 2
... A factor, once known as oscillin, carried by ... oscillations in free calcium necessary to bring about a ... is a strong candidate for oscillin. Eventually PLCZ1 undergoes ... to promote calcium oscillations ceases. One would reasonably think ...
... Representatives not to Concur on Senate Budget,which Includes Elimination ... May 23 Many older,Illinoisans were left out of ... includes severe cuts to several programs and,services that allow ... own choice and avoid costly and premature,institutional care. AARP ...
... 23 Watson,Pharmaceuticals, Inc. (NYSE: WPI ), ... Bisaro, Watson,s president and chief,executive officer, will provide ... the UBS Global Specialty and Generic Pharmaceuticals Conference,on ... BST (9:30 a.m. EDT)., This presentation will ...
... the Army,s 2nd Battalion, 113th Infantry Regiment yesterday ... for their upcoming,deployment in Iraq. Instead of shooting ... procedure that allows them to have 20/20 vision ... Drs. Joseph and Jeffery Dello Russo marked ...
... In response to the,devastating 7.9 magnitude earthquake that ... public and corporations have generously supported,American Red Cross ... grateful for the outpouring of compassion,we,ve received from ... Meltzer, senior vice president, International Services for the,American ...
... condition can strike anyone , , FRIDAY, May 23 (HealthDay News) ... a four-time NBA All-Star, and head coach of the Philadelphia ... gout. , "I had no idea what gout was," Cheeks ... 46 -- with the often-debilitating arthritic condition. "Never heard of ...
Cached Medicine News:Health News:June 2008 highlights 2Health News:Soldiers Receive Free Memorial Day Lasik Surgery Before Going to Iraq 2Health News:America Generously Responds to China Earthquake 2Health News:Basketball Star Details His Struggle With Gout 2Health News:Basketball Star Details His Struggle With Gout 3
(Date:9/2/2015)... , Sept. 2, 2015  RegeneRx Biopharmaceuticals, ... clinical-stage drug development company focused on tissue protection, ... Finkelstein , President and Chief Executive Officer, will ... Renshaw Global Investment Conference, sponsored by H.C. ... held September 8-10, 2015 at the St. Regis ...
(Date:9/2/2015)... Sept. 2, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... its affiliate has entered into a definitive agreement under ... , Inc. (NASDAQ: SURG ) for $6.50 per ... payment, Synergetics stockholders will receive additional cash payments of ... are achieved following the closing.  The transaction is expected ...
(Date:9/2/2015)... , Sept. 2, 2015 Tumultuous market ... frenzy of health care M&A activity – have led ... access restrictions on pharmaceutical sales reps. This marks the ... access has crossed the halfway point, according to the ... and marketing firm ZS . ...
Breaking Medicine Technology:RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5Crossing the threshold: More than half of physicians restrict access to sales reps 2Crossing the threshold: More than half of physicians restrict access to sales reps 3Crossing the threshold: More than half of physicians restrict access to sales reps 4Crossing the threshold: More than half of physicians restrict access to sales reps 5
... Limited (the "Company") and Celtic Therapeutics Holdings LP ("Celtic ... clinical trial of SG2000 in ovarian cancer.  The trial ... of the USA, and is now actively recruiting patients ... will evaluate the overall response rate of SG2000 in ...
... (NYSE: AZN ) today announced that ... extended the time to complete its review of ... (Logo: http://photos.prnewswire.com/prnh/20091027/PH99766LOGO) (Logo: ... Prescription Drug User Fee Act (PDUFA) date from ...
Cached Medicine Technology:Commencement of a Phase II Clinical Trial of SG2000 in Ovarian Cancer 2Commencement of a Phase II Clinical Trial of SG2000 in Ovarian Cancer 3U.S. Food and Drug Administration Extends Review Timeline for BRILINTA (Ticagrelor) New Drug Application 2
... Thyroid Autoimmunity Test is an enzyme immunoassay ... autoantibodies against human thyroglobulin and human thyroid ... blood and is used as an aid ... thyroid gland disorders are characterized by detection ...
The ImmunoWELL TPO IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroid peroxidase (microsome) in serum and is used as ...
... The ImmunoDOT Autoimmunity Screening Panel 1 ... for screening and detection of autoantibodies ... DNA, SS-A/SS-B, RNP/Sm) in serum, and ... the diagnosis of systemic lupus erythematosus ...
... Autoimmunity Screening Panel 4 is an ... and detection of autoantibodies against various ... RNP/Sm, and Sm) in serum, and ... the diagnosis of systemic lupus erythematosus ...
Medicine Products: